Ambeed.cn

首页 / / / / Ilomastat/伊洛马司他

Ilomastat/伊洛马司他 {[allProObj[0].p_purity_real_show]}

货号:A237914 同义名: GM6001; Galardin

Ilomastat(GM6001) 是一种高效的广谱基质金属蛋白酶 (MMP) 抑制剂,对 MMP-1、MMP-2、MMP-3 和 MMP-9 的 IC50 值分别为 1.5 nM、1.1 nM、1.9 nM 和 0.5 nM,对人皮肤成纤维细胞胶原酶 (MMP-1) 的 Ki 为 0.4 nM。

Ilomastat/伊洛马司他 化学结构 CAS号:142880-36-2
Ilomastat/伊洛马司他 化学结构
CAS号:142880-36-2
Ilomastat/伊洛马司他 3D分子结构
CAS号:142880-36-2
Ilomastat/伊洛马司他 化学结构 CAS号:142880-36-2
Ilomastat/伊洛马司他 3D分子结构 CAS号:142880-36-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Ilomastat/伊洛马司他 纯度/质量文件 产品仅供科研

货号:A237914 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 MMP 其他靶点 纯度
Marimastat +++

MMP-7, IC50: 16 nM

MMP-14, IC50: 3 nM

98%
Ilomastat ++++

MMP-26, Ki: 0.36 nM

MMP-2, Ki: 0.1 nM

99%+
SB-3CT +

MMP-9, Ki: 600 nM

MMP-2, Ki: 13.9 nM

99%+
Doxycycline 95%
NSC 405020 98%
Batimastat +++

MMP-7, IC50: 4 nM

MMP-1, IC50: 3 nM

99%+
Nobiletin 99%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Ilomastat/伊洛马司他 生物活性

靶点
  • MMP

    MMP-26, Ki:0.36 nM

    MMP-2, Ki:0.1 nM

描述 GM 6001 is a broad spectrum MMP inhibitor with Ki values of 0.1nM, 0.2nM, 0.36nM, 0.4nM, 0.5nM, 3.6nM and 3.7nM for MMP-8, MMP-9, MMP-26, MMP-1, MMP-2, MMP-12 and MMP-7[1]. The tyrosine phosphorylation of EGFR induced by leptin could be significantly attenuated by treatment with 25μM GM6001 for 30min in rat aortic smooth muscle cells, due to the inhibition of proteolytic cleavage of transmembrane precursors via matrix metalloproteinase by GM6001[2]. Inhibition of MMP-2/MMP-9-mediated NCAM (Neural cell adhesion molecule) proteolysis by administration of 5μg GM6001 through intracerebroventricular route 30 minutes before and 2 h after ischemia attenuated the infarction, behavioral abnormalities of MCAO (middle cerebral artery occlusion) model mice, with suppression on the level of NCAM cleavage product by GM6001 observed[3].

Ilomastat/伊洛马司他 细胞实验

Cell Line
Concentration Treated Time Description References
U87 glioblastoma cells 10 µM 24 hours Increased An2 internalization Int J Mol Sci. 2022 Nov 17;23(22):14214
Ly6G+ neutrophils 50 µM 8 hours To evaluate the effect of Ilomastat on the migration ability of Ly6G+ neutrophils from leukemic mice. Results showed that Ilomastat significantly inhibited the migration ability of neutrophils from leukemic mice, while having no effect on neutrophils from naive mice. Exp Hematol Oncol. 2024 May 10;13(1):49
C6 glioma cells 0, 25, 50, 75, or 100 μM 24 hours To evaluate the inhibitory effect of Ilomastat on MMP3 activity secreted by C6-Cx43 cells. Results showed that Ilomastat inhibited MMP3 activity in a concentration-dependent manner. J Enzyme Inhib Med Chem. 2020 Dec;35(1):672-681
juvenile equine tendon and ligament myofibroblasts 10 µg/mL and 20 µg/mL 24 hours To evaluate the effect of Ilomastat on the viability and proliferation capacity of juvenile equine tendon and ligament myofibroblasts. Results showed no significant negative impact on cell viability and proliferation at the tested concentrations. Sci Rep. 2025 May 6;15(1):15762
HrasA5 cells 10 µM 3 weeks Inhibition of MMP activity prevented invasive growth of HrasA5 cells Front Oncol. 2022 Jan 31;12:827985
Human Tenon fibroblast cells (HTFs) 0.01, 1, 10, 100 μM 7 days To evaluate the inhibitory effect of Ilomastat-CD on collagen gel contraction. Results showed that Ilomastat-CD significantly inhibited collagen gel contraction at concentrations ranging from 1 to 100 μM, similar to uncomplexed Ilomastat. Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3425-3431

Ilomastat/伊洛马司他 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice FGFR1-driven leukemia model Intraperitoneal injection 100 mg/kg 7 consecutive days To evaluate the effect of Ilomastat on survival and immune cell composition in leukemic mice. Results showed that Ilomastat treatment significantly prolonged survival of leukemic mice, reduced leukemic cells and PMN-MDSCs in peripheral blood, and increased T-cell levels. Exp Hematol Oncol. 2024 May 10;13(1):49
Mice CFTR knockout mice Intratracheal administration 50 µM and 150 µM Single dose, monitored at 4, 24, and 48 hours Evaluate the effect of Ilomastat on lung inflammation; results showed 150 μM Ilomastat significantly reduced inflammation in CF mice Virulence. 2018;9(1):1008-1018
New Zealand White rabbits Topical eye drop 100 μL (1 mg/mL) Single dose, sampled after 4 hours To assess the distribution of Ilomastat-CD in ocular tissues. Results showed therapeutic concentrations of Ilomastat in sclera, conjunctiva, and aqueous humor. Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3425-3431
C57BL/6J wild-type and CFTR knockout mice Acute lung infection model Intratracheal administration 150 µM Administered 20 hours post-infection, monitored at 4 and 24 hours To evaluate the anti-inflammatory effects of Ilomastat in acute P. aeruginosa lung infection. Results showed that Ilomastat reduced IL-8-dependent bioluminescence signal, indicating reduced inflammation. Clin Exp Immunol. 2021 Jan;203(1):87-95
New Zealand white rabbits Experimental glaucoma filtration surgery model Subconjunctival injection 100 μM Single injection, lasted for 28 days To evaluate the safety of Ilomastat in glaucoma filtration surgery, results showed that Ilomastat had less toxicity on rabbit cornea, conjunctiva, and ciliary body compared to MMC. J Korean Med Sci. 2017 Apr;32(4):666-671

Ilomastat/伊洛马司他 动物研究

Dose Hamster: 20 mg/kg[4] (i.p.) Rat: 1.2 mg/kg[5] (i.p.); 50 mg/kg, 100 mg/kg[6] (i.p.)
Administration i.p.

Ilomastat/伊洛马司他 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03297827 - Recruiting August 27, 2019 United States, New Mexico ... 展开 >> Department of Neurology, University of New Mexico Recruiting Albuquerque, New Mexico, United States, 87131-0007 Contact: Asad Ikram, MD    505-272-9382    aikram@salud.unm.edu    Principal Investigator: Atif Zafar, MD          Sub-Investigator: Asad Ikram, MD 收起 <<

Ilomastat/伊洛马司他 参考文献

[1]Grobelny D, Poncz L, et al. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry. 1992 Aug 11;31(31):7152-4.

[2]Chao HH, Hong HJ, et al. Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Eur J Pharmacol. 2007 Nov 14;573(1-3):49-54. Epub 2007 Jul 4.

[3]Shichi K, Fujita-Hamabe W, et al. Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. J Pharmacol Exp Ther. 2011 Aug;338(2):701-10.

Ilomastat/伊洛马司他 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.87mL

2.57mL

1.29mL

25.74mL

5.15mL

2.57mL

Ilomastat/伊洛马司他 技术信息

CAS号142880-36-2
分子式C20H28N4O4
分子量 388.46
SMILES Code O=C(N[C@@H](CC1=CNC2=C1C=CC=C2)C(NC)=O)[C@H](CC(C)C)CC(NO)=O
MDL No. MFCD00917040
别名 GM6001; Galardin
运输蓝冰
InChI Key NITYDPDXAAFEIT-DYVFJYSZSA-N
Pubchem ID 132519
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, 2-8°C

溶解方案

DMSO: 45 mg/mL(115.84 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
方案 四
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。